Printer-friendly version
Trade deal will hurt—not help—COVID vaccine mission

The biopharmaceutical industry is uniquely prepared to combat COVID-19.

Printer-friendly version
USMCA will stunt potentially lifesaving innovation

Breakthrough medicines take an average of 10 to 15 years of research and development—and $2.6 billion—before reaching market.

Printer-friendly version
Congressional voting on USMCA underscores influence of interest groups

Recent study found that legislator votes coincided with the positions of their constituents only 65 per cent of the time.

Printer-friendly version
Canadian cheers over pending USMCA may be short-lived

Stronger enforcement of labour provisions will likely increase manufacturing costs in Mexico.

Printer-friendly version
Canada can’t escape Trump administration’s war on trade

The president slapped tariffs on Canadian steel and aluminum exports during USMCA negotiations.

Printer-friendly version
Trump’s tariff tactics will end badly for U.S.—and Canada

Besides reducing their trade and investment linkages, foreign businesses may also reduce their reliance on the U.S. dollar.

Printer-friendly version
NAFTA renegotiations—a missed opportunity for Canada

Protections for domestic producers of transportation, broadcasting and commercial banking remain essentially untouched.

Printer-friendly version

The Democratic takeover of the House likely won’t affect U.S. tariffs on Canadian steel and aluminum exports.

Printer-friendly version
New trade deal increases American sway over Canada

This is clearly an “America First” agreement.